Investor4321

Investor4321

Zai Lab has partnered with Five Prime Therapuetics in the making and testing of the cancer treatment drug FPA144 + chemo (FIGHT). The stock is projected to rise 20+% on Friday, January 15, when the data is released. The data will be released 10:00-11:15 EST. Like and Follow if you want to see more trades like this.

Investor4321

This stock is going to be the next Tesla. They are producing better and better products, and should eventually reach highs like $200-$500.

Investor4321

RCUS releases phase one clinical trial data for a drug they are developing to treat pancreatic cancer on Friday, January 15-17. Look to buy about a week in advance.

Investor4321

This company is releasing data for phase one clinical trial data for a cancer treatment drug. The risk is high, but if the data is good, The stock could rise 200+%.

Investor4321

Five Prime Therapeutics is developing a highly effective cancer treatment. Currently, they are on phase two of their clinical trials. When they released their phase one data on November tenth, the stock rose 200%+. On January 15, 2021, they will release phase two trial data. If the data is good, you could be looking at 50-100% gains.